Home > Drug Search >
  • company_query: Aquilus Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (10) biology (4)
Status:
Approved (1) NDA Filing (1) Phase Ⅲ (1) Phase Ⅱ (6) Phase Ⅰ (5)
Clinical Stage:
Pending (1) Active (10) Discontinued (2)
Bio-Type:
Cell therapy (1) Recombinant cytokines (1) Whole antibody (1)
Indication:
Actinic keratosis (AK) (1) Acute myeloid Leukemia (AML) (1) Attention deficit hyperactivity disorder (ADHD) (1) Breast cancer (1) Coronary artery disease (CAD) (1) Crohn's disease (1) Dementia (1) wound (1) Melanoma (1) Myelodysplastic syndrome (MDS) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Peptic ulcer (1) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Systemic lupus erythematosus (1) Diabetic foot ulcers (1) Pain (1) Ischemic stroke (1) Glioblastoma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top